![]() |
市場調查報告書
商品編碼
1963825
光聲成像市場-全球產業規模、佔有率、趨勢、機會與預測:按產品、類型、應用、地區和競爭對手分類,2021-2031年Photoacoustic Imaging Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Photoacoustic Tomography, Photoacoustic Microscopy ), By Type, By Application, By Region & Competition, 2021-2031F |
||||||
全球光聲成像市場預計將從 2025 年的 8,428 萬美元成長到 2031 年的 1.5351 億美元,複合年成長率為 10.51%。
作為一種混合生物醫學技術,它利用光聲效應,結合了光學成像的高對比和超音波的深層組織穿透能力。該領域的發展主要受慢性疾病(尤其是癌症和心血管疾病)日益普遍的推動。這些疾病需要能夠進行功能性影像的非侵入性診斷方法。該技術無需使用電離輻射即可繪製血氧飽和度和血紅蛋白水平圖,進一步加劇了這項需求。鑑於美國癌症協會預測2024年美國將新增2,001,140例癌症病例,這項技術顯得格外重要。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 8428萬美元 |
| 市場規模:2031年 | 1.5351億美元 |
| 複合年成長率:2026-2031年 | 10.51% |
| 成長最快的細分市場 | 光聲成像(PAT) |
| 最大的市場 | 北美洲 |
儘管存在這些市場促進因素,但由於設備高成本以及系統操作所需的技術複雜性,市場成長仍面臨許多挑戰。這些雙模態系統所需的大量資本投入造成了財務壁壘,使得採購主要局限於大型研究機構,而小規模臨床機構則被排除在外。此外,目前尚無針對光聲成像程序的既定報銷代碼,這限制了該技術融入標準臨床工作流程,從而阻礙了其商業性化應用。
高解析度混合成像系統的技術突破正在推動其快速發展,克服了掃描速度和影像品質的傳統限制。雷射技術和超音波換能器的進步使得設備能夠以卓越的清晰度提供即時功能性資訊。例如,2024年9月,倫敦大學學院的研究人員開發了一種手持式掃描儀,其生成精細3D光聲影像的速度比以往型號快100到1000倍,有效消除了運動模糊。這些性能提升得到了臨床證據的支持。 2024年10月發表在《學術放射學》雜誌上的一項關於Cenomedical公司第二代Imagio乳房攝影成像系統的研究證實,該系統在區分良性和惡性腫瘤方面具有100%的靈敏度,凸顯了將這些成像方式整合到常規臨床實踐中的潛力。
此外,慢性病(尤其是心血管疾病)發生率的上升,使得對非侵入性、無輻射診斷設備的需求日益成長。光聲成像技術非常適合心血管疾病患者所需的頻繁監測,因為它無需使用電離輻射即可繪製血氧飽和度圖並識別血管異常。高死亡率進一步凸顯了這項臨床需求。根據美國疾病管制與預防中心 (CDC) 統計,2023 年美國有 919,032 人死於心血管疾病。隨著醫療保健系統更加重視早期檢測以降低死亡率,對能夠同時提供功能和解剖數據的檢測方式的需求不斷成長,預計這將推動該技術在心血管領域的更廣泛應用。
全球光聲成像市場的主要阻礙因素是高昂的設備成本和缺乏完善的健保報銷機制,這造成了巨大的經濟障礙。此類混合系統所需的資本投入對於地方醫院和私人診所而言往往難以承受,這種經濟負擔極大地限制了目標市場。因此,該技術的應用仍集中在資金雄厚的研究機構,難以實現大規模臨床應用,因此無法實現商業性規模化,也使其市場始終局限於小眾領域而非大眾市場。
此外,由於缺乏具體的報銷代碼,投資回報存在很大的不確定性。這令依賴保險支付營運成本的潛在買家望而卻步。醫療影像領域本已面臨預算限制,日益收緊的財務環境更加劇了這種猶豫。例如,美國放射學會 (ACR) 指出,根據聯邦醫療保險醫師收費標準 (PFS),診斷放射學領域在 2024 年將面臨約 4% 的報銷削減。這種財務限制迫使醫療服務提供者優先考慮成熟的必要技術,而非新興技術,從而有效地阻礙了光聲成像技術的市場整合。
將人工智慧 (AI) 應用於影像重建以提高其準確性,正透過實現精確的定量分析和提升診斷準確率,徹底改變市場格局。深度學習演算法正被擴大用於提取量化生物標記的放射組學特徵,從而克服傳統重建方法在定性分析方面的局限性。這項進展在腫瘤學領域尤其重要,因為功能性見解對於指南治療至關重要。一項發表於 2025 年 1 月《生物醫學工程在線》(BioMedical Engineering Online) 的臨床回顧性研究,納入了 223 例乳癌患者,檢驗了基於光聲技術的放射組學列線圖在預測 Ki-67 表達水平方面的有效性,展現了其作為臨床非侵入性分子表徵技術的潛力。
同時,隨著混合多模態影像平台的普及,這項技術的效用正從診斷影像擴展到治療導引領域。製造商正在開發將光聲成像與射頻超音波和高強度聚焦超音波(HIFU)等治療方式相結合的系統,從而在介入治療過程中提供即時回饋。這些混合設備能夠同時進行解剖定位和功能監測,並達到精準治療。例如,在2025年9月出版的《雷射與光子學評論》(Laser & Photonics Reviews)上,研究人員詳細介紹了一種配備20.0 MHz單元件換能器的雙模系統。該系統結合了高解析度成像和治療功能,有效地彌合了診斷篩檢和影像引導治療之間的差距。
The Global Photoacoustic Imaging Market is projected to expand from USD 84.28 Million in 2025 to USD 153.51 Million by 2031, registering a CAGR of 10.51%. As a hybrid biomedical modality, this technology utilizes the photoacoustic effect to merge the high contrast of optical imaging with the deep tissue penetration capabilities of ultrasound. Growth in this sector is primarily fueled by the increasing prevalence of chronic diseases, specifically cancer and cardiovascular disorders, which necessitates non-invasive diagnostics capable of functional imaging. This demand is further amplified by the technology's capacity to map blood oxygenation and hemoglobin levels without utilizing ionizing radiation, a critical need given that the American Cancer Society projected 2,001,140 new cancer cases in the United States in 2024.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 84.28 Million |
| Market Size 2031 | USD 153.51 Million |
| CAGR 2026-2031 | 10.51% |
| Fastest Growing Segment | Photoacoustic Tomography (PAT) |
| Largest Market | North America |
Despite these drivers, market growth faces significant obstacles due to the high costs associated with equipment and the technical complexity required for system operation. The substantial capital investment necessary for these dual-modality systems limits procurement largely to major research institutions, creating a financial barrier that excludes smaller clinical environments. Furthermore, the absence of established reimbursement codes for photoacoustic procedures creates a hurdle for widespread commercial adoption, restricting the integration of this technology into standard clinical workflows.
Market Driver
Technological breakthroughs in high-resolution hybrid imaging systems act as a major growth catalyst by resolving historical limitations regarding scan speed and image quality. Improvements in laser technology and ultrasound transducers now allow devices to deliver real-time functional insights with exceptional clarity. For example, in September 2024, researchers at University College London developed a handheld scanner capable of producing detailed 3D photoacoustic images 100 to 1,000 times faster than previous models, effectively eliminating motion-induced blurring. These performance enhancements are supported by clinical evidence; a study published in Academic Radiology in October 2024 regarding Seno Medical's second-generation Imagio Breast Imaging System reported an observed 100 percent sensitivity in distinguishing between benign and malignant masses, underscoring the feasibility of integrating these modalities into routine workflows.
Additionally, the increasing incidence of chronic conditions, especially cardiovascular diseases, drives the need for non-invasive and radiation-free diagnostic instruments. The ability of photoacoustic imaging to map blood oxygenation and identify vascular abnormalities without ionizing radiation makes it ideal for the frequent monitoring required for heart and vascular patients. This clinical necessity is emphasized by the heavy mortality burden, with the Centers for Disease Control and Prevention reporting that 919,032 individuals in the United States died from cardiovascular disease in 2023. As healthcare systems focus on early detection to reduce mortality rates, the demand for modalities providing both functional and anatomical data is set to rise, fostering broader adoption within cardiology and vascular departments.
Market Challenge
The primary factors restraining the Global Photoacoustic Imaging Market are the substantial financial barriers arising from high equipment costs and the lack of established reimbursement codes. This economic burden severely limits the addressable market, as the capital expenditure needed for such hybrid systems is often too high for community hospitals and private clinics to justify. As a result, adoption remains concentrated within well-funded research institutions, preventing the technology from reaching the high-volume clinical utilization required for widespread commercial scalability and keeping the market niche rather than mass-market oriented.
Moreover, the absence of specific reimbursement codes generates significant uncertainty regarding return on investment, which discourages potential buyers who depend on insurance payments to cover operational expenses. This hesitation is intensified by a tightening fiscal climate in the medical imaging sector, where budgets are already under pressure. For instance, the American College of Radiology noted that in 2024, diagnostic radiology faced an estimated reimbursement reduction of approximately 4% under the Medicare Physician Fee Schedule. Such financial constraints compel healthcare providers to favor essential, established modalities over emerging technologies, effectively stalling the market integration of photoacoustic imaging.
Market Trends
The integration of Artificial Intelligence for Enhanced Image Reconstruction is revolutionizing the market by facilitating precise quantitative analysis and elevating diagnostic accuracy. Deep learning algorithms are increasingly utilized to extract radiomic features that quantify biological markers, thereby transcending the qualitative limitations associated with traditional reconstruction methods. This advancement is particularly vital in oncology, where functional insights are essential for guiding treatment; a retrospective clinical study published in BioMedical Engineering OnLine in January 2025 involving 223 breast cancer patients validated a photoacoustic-based radiomic nomogram to predict Ki-67 expression levels, highlighting the technology's potential for non-invasive molecular characterization in clinical environments.
Simultaneously, the proliferation of hybrid multimodal imaging platforms is extending the utility of this technology beyond diagnostic imaging to include therapeutic guidance. Manufacturers are creating integrated systems that merge photoacoustic imaging with high-frequency ultrasound and therapeutic modalities, such as High-Intensity Focused Ultrasound (HIFU), to offer real-time feedback during interventions. These hybrid devices enable simultaneous anatomical mapping and functional monitoring to ensure precise treatment delivery. For example, researchers detailed in Laser & Photonics Reviews in September 2025 the introduction of a dual-mode system equipped with a single-element 20.0 MHz transducer capable of performing high-resolution imaging alongside therapeutic functions, effectively bridging the gap between diagnostic screening and image-guided therapy.
Report Scope
In this report, the Global Photoacoustic Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Photoacoustic Imaging Market.
Global Photoacoustic Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: